IMA vs PHM · rev $9.2M vs P/E 7.7, rev $17.95B
ImageneBio, Inc. (IMA) versus PulteGroup Inc (PHM) — a side-by-side from cached financials, not a winner call.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
PulteGroup Inc (PHM) is a residential construction company listed on US.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
Latest reported PHM revenue for 2024-12-31 was $17.95B. Net income was $3.08B. Revenue was up 11.7% from 2023-12-31 to 2024-12-31. PHM currently screens at market cap $21.92B and trailing P/E 7.7.
IMA currently screens at market cap $64.7M. PHM currently screens at market cap $21.92B and trailing P/E 7.7.
Not investment advice. Open the IMA and PHM stock pages for the full models.
Not investment advice.